Washington Trust CO Gilead Sciences, Inc. Transaction History

Washington Trust CO

$2.83 Billion
Q3 2024

A detailed history of Washington Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Washington Trust CO holds 750 shares of GILD stock, worth $66,060. This represents 0.0% of its overall portfolio holdings.

Number of Shares

750

Previous 750 -0.0%

Holding current value

$66,060

Previous $51,000 21.57%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	SELL	$71.58 - $87.29 $2,147 - $2,618	-30 Reduced 3.85%	750 $54,000
Q2 2023 Jul 27, 2023	BUY	$76.01 - $86.7 $532 - $606	7 Added 0.91%	780 $60,000
Q1 2023 May 10, 2023	BUY	$77.31 - $88.08 $60,224 - $68,614	779 Added 77900.0%	780 $64,000
Q1 2023 May 04, 2023	SELL	$77.31 - $88.08 $59,683 - $67,997	-772 Reduced 99.87%	1 $65,000
Q4 2022 Jul 27, 2023	SELL	$62.32 - $89.47 $436 - $626	-7 Reduced 0.9%	773 $66,000
Q4 2022 Feb 08, 2023	BUY	$62.32 - $89.47 $1,433 - $2,057	23 Added 3.07%	773 $66,000
Q3 2022 Oct 14, 2022	SELL	$59.54 - $68.01 $4,465 - $5,100	-75 Reduced 9.09%	750 $46,000
Q4 2021 Feb 09, 2022	SELL	$64.88 - $73.64 $59,689 - $67,748	-920 Reduced 52.72%	825 $59,000
Q2 2021 Aug 05, 2021	SELL	$63.47 - $69.35 $19,041 - $20,805	-300 Reduced 14.67%	1,745 $120,000
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $13,596 - $15,492	-240 Reduced 10.5%	2,045 $119,000
Q3 2020 Nov 05, 2020	BUY	$62.1 - $78.08 $53,095 - $66,758	855 Added 59.79%	2,285 $145,000
Q2 2020 Aug 04, 2020	SELL	$72.34 - $84.0 $1,808 - $2,100	-25 Reduced 1.72%	1,430 $107,000
Q1 2020 May 07, 2020	BUY	$62.63 - $80.22 $91,126 - $116,720	1,455 New	1,455 $109,000
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $135,503 - $150,026	-1,901 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$64.88 - $75.68 $90,183 - $105,195	1,390 Added 272.02%	1,901 $135,000
Q1 2018 May 10, 2018	SELL	$72.84 - $88.8 $37,221 - $45,376	-511 Reduced 50.0%	511 $39,000
Q4 2017 Feb 05, 2018	SELL	$71.15 - $83.52 $240,415 - $282,214	-3,379 Reduced 76.78%	1,022 $74,000
Q3 2017 Oct 31, 2017	BUY	$72.11 - $85.47 $317,356 - $376,153	4,401	4,401 $356,000

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust CO with notifications on news.

Account

Washington Trust CO Gilead Sciences, Inc. Transaction History